An antimicrobial peptide that inhibits translation by trapping release factors on the ribosome.
Florin, T., Maracci, C., Graf, M., Karki, P., Klepacki, D., Berninghausen, O., Beckmann, R., Vazquez-Laslop, N., Wilson, D.N., Rodnina, M.V., Mankin, A.S.(2017) Nat Struct Mol Biol 24: 752-757
- PubMed: 28741611 Search on PubMedSearch on PubMed Central
- DOI: https://doi.org/10.1038/nsmb.3439
- Primary Citation Related Structures: 
5O2R - PubMed Abstract: 
Many antibiotics stop bacterial growth by inhibiting different steps of protein synthesis. However, no specific inhibitors of translation termination are known. Proline-rich antimicrobial peptides, a component of the antibacterial defense system of multicellular organisms, interfere with bacterial growth by inhibiting translation. Here we show that Api137, a derivative of the insect-produced antimicrobial peptide apidaecin, arrests terminating ribosomes using a unique mechanism of action. Api137 binds to the Escherichia coli ribosome and traps release factor (RF) RF1 or RF2 subsequent to the release of the nascent polypeptide chain. A high-resolution cryo-EM structure of the ribosome complexed with RF1 and Api137 reveals the molecular interactions that lead to RF trapping. Api137-mediated depletion of the cellular pool of free release factors causes the majority of ribosomes to stall at stop codons before polypeptide release, thereby resulting in a global shutdown of translation termination.
- Center for Biomolecular Sciences, University of Illinois at Chicago, Chicago, Illinois, USA.
Organizational Affiliation: 









































































